EMCURE PHARMACEUTICALS
Back to Cashflow Statement
|
EMCURE PHARMACEUTICALS Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹852 Cr | ₹1,097 Cr | ₹747 Cr | ₹768 Cr | ₹704 Cr |
What is the latest Cash Flow from Operating Activities ratio of EMCURE PHARMACEUTICALS ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹852 Cr |
| Mar2024 | ₹1,097 Cr |
| Mar2023 | ₹747 Cr |
| Mar2022 | ₹768 Cr |
| Mar2021 | ₹704 Cr |
How is Cash Flow from Operating Activities of EMCURE PHARMACEUTICALS Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹852 Cr | -22.38 | |
| Mar2024 | ₹1,097 Cr | 46.92 | |
| Mar2023 | ₹747 Cr | -2.78 | |
| Mar2022 | ₹768 Cr | 9.05 | |
| Mar2021 | ₹704 Cr | - | |
Compare Cash Flow from Operating Activities of peers of EMCURE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| EMCURE PHARMACEUTICALS | ₹35,181.8 Cr | -1.5% | 9.2% | 37.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹449,048.0 Cr | 0.5% | 4.6% | 11.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹177,179.0 Cr | -0.6% | 2.2% | -0.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹157,804.0 Cr | 3.2% | 8.1% | 43.9% | Stock Analytics | |
| CIPLA | ₹117,642.0 Cr | 1.1% | 5.6% | -3.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹112,368.0 Cr | -0.3% | 5.6% | -0.1% | Stock Analytics | |
EMCURE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| EMCURE PHARMACEUTICALS | -1.5% |
9.2% |
37.2% |
| SENSEX | 0.7% |
4.4% |
-5.6% |
You may also like the below Video Courses